Drugs / TV P2-VP8
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04010448 | Oct 2019 → Dec 2025 | Rotavirus infection | PATH | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TV P2-VP8 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04010448 ↗ |
| Modality | Vaccine | “A novel parenteral rotavirus subunit vaccine (TV P2-VP8)” PMID 41319434 ↗ Nov 2025 |
| Route | Intramuscular | “90 µg of the TV P2-VP8 vaccine IM plus oral placebo administered on study days 1, 29 and 57” NCT04010448 ↗ |